Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Global Gene Editing Technology Market Growth (Status and Outlook) 2024-2030
... engineering technology that can modify specific target genes in the genome of an organism. Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments. Gene ... Read More
-
2024-2028 Global BUN (Blood Urea Nitrogen) Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, ... Read More
-
2024-2028 Global Protein Electrophoresis Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, ... Read More
-
2024-2028 Global Capillary Electrophoresis Market: APAC, Europe, India, LatAm, Middle East, North America—Supplier Sales, Shares and Forecasts for Geographic Regions, Market Segments and Applications
... available from any other source, including 51 tables. Geographic Regions The report provides 2023 supplier sales, shares and 2023-2028 forecasts for the following regions: Global Asia-Pacific Europe India Latin America Middle East North America Rest ... Read More
-
2024-2028 Global Cannabinoids/Marijuana Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Global Herpes Testing (Simplex I/II, Type VI) in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, ... Read More
-
Global Cell and Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Cell and Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Healthcare Contract Development and Manufacturing Organization
... the year 2023, is expected to reach US$547.1 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Contract Manufacturing, one of the segments analyzed in the report, is expected to ... Read More
-
Synthetic Genes
... at a CAGR of 17.7% over the analysis period 2023-2030. Pharmaceuticals & Diagnostics Application, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$9.8 Billion by the ... Read More
-
Biomaterials
... of 11.3% over the analysis period 2023-2030. Metallic Biomaterials, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$119.1 Billion by the end of the analysis period. ... Read More
-
Hereditary Testing
... at a CAGR of 6.1% over the analysis period 2023-2030. Preimplantation Genetic Diagnosis & Screening Test, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$4.6 Billion ... Read More
-
Immunofluorescence Assays
... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More
-
In Vitro Protein Expression Systems
... is expected to reach US$307.5 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. E-Coli, one of the segments analyzed in the report, is expected to record a 5.0% CAGR ... Read More
-
Patient Derived Xenograft / PDX Models
... the year 2023, is expected to reach US$510.8 Million by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Pre-Clinical Drug Development Application, one of the segments analyzed in the report, is ... Read More
-
Plasma Protease C1-inhibitor Treatment
... reach US$18.1 Billion by 2030, growing at a CAGR of 20.1% over the analysis period 2023-2030. C1-Inhibitor, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$8.8 ... Read More
-
Polymerase Chain Reaction Consumables
... reach US$606.9 Million by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach ... Read More
-
Primary Immunodeficiency Therapeutics
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Antibody Deficiency Disease Type, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$8.5 ... Read More
-
Cancer Stem Cells
... by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 ... Read More
-
Immunohistochemistry
... of 7.1% over the analysis period 2023-2030. Immunohistochemistry Antibodies, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Automated Microscopy
... at a CAGR of 7.0% over the analysis period 2023-2030. Optical Microscopes, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$8.8 Billion by the end of ... Read More
-
Photopheresis Products
... at a CAGR of 5.4% over the analysis period 2023-2030. Photopheresis Open System, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$164.4 Million by the end ... Read More
-
Breast Cancer Liquid Biopsy
... reach US$1.1 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. Reagent Kits, one of the segments analyzed in the report, is expected to record a 22.0% CAGR and reach ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing
... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 13.1% ... Read More
-
Genomics in Cancer Care
... reach US$62.1 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$25.0 ... Read More
-
High Throughput Process Development
... reach US$24.6 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Monoclonal Antibodies Molecule Type, one of the segments analyzed in the report, is expected to record a 9.0% CAGR ... Read More
Research Assistance
